XML 45 R33.htm IDEA: XBRL DOCUMENT
v3.23.1

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Fair Value Disclosures [Abstract] |
Fair value, assets measured on recurring basis |
Fair value, assets measured on recurring basis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Fair Value Measurement at March 31, 2023 |
|  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Investment in common stock of Alzamend Neuro, Inc. (“Alzamend”) – a related party |  | $ | 4,856,000 |  |  | $ | 4,856,000 |  |  | $ | - |  |  | $ | - |
Investments in marketable equity securities |  |  | 1,367,000 |  |  |  | 1,367,000 |  |  |  | - |  |  |  | - |
Cash and marketable securities held in trust account |  |  | 119,254,000 |  |  |  | 119,254,000 |  |  |  | - |  |  |  | - |
Total assets measured at fair value |  | $ | 125,477,000 |  |  | $ | 125,477,000 |  |  | $ | - |  |  | $ | - |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series E, F and G preferred stock liabilities |  | $ | 8,500,000 |  |  | $ | - |  |  | $ | - |  |  | $ | 8,500,000 |
Convertible promissory notes |  |  | 15,283,000 |  |  |  | - |  |  |  | - |  |  |  | 15,283,000 |
Total liabilities measured at fair value |  | $ | 23,783,000 |  |  | $ | - |  |  | $ | - |  |  | $ | 23,783,000 |
|  | Fair Value Measurement at December 31, 2022 |
|  |  | Total |  |  |  | Level 1 |  |  |  | Level 2 |  |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in common stock of Alzamend – a related party |  | $ | 6,449,000 |  |  | $ | 6,449,000 |  |  | $ | - |  |  | $ | - |
Investments in marketable equity securities |  |  | 6,590,000 |  |  |  | 6,590,000 |  |  |  | - |  |  |  | - |
Cash and marketable securities held in trust account |  |  | 118,193,000 |  |  |  | 118,193,000 |  |  |  | - |  |  |  | - |
Investments in other equity securities |  |  | 13,340,000 |  |  |  | - |  |  |  | - |  |  |  | 13,340,000 |
Total assets measured at fair value |  | $ | 144,572,000 |  |  | $ | 131,232,000 |  |  | $ | - |  |  | $ | 13,340,000 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible promissory notes |  | $ | 12,776,000 |  |  | $ | - |  |  | $ | - |  |  | $ | 12,776,000 |
Schedule of investments |
Schedule of investments |  |  |
|  | Investments in other equity securities
Balance at January 1, 2023 |  | $ | 13,340,000
Conversion to Level 1 marketable securities |  |  | (13,340,000)
Balance at March 31, 2023 |  | $ | -

X
- References No definition available. + Details
Name: | ault_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock
Namespace Prefix: | ault_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration